Developer docs
API playgroundTry for free, no card

Search company profiles

IDE Group

Full company profile

uuid0003ebt

Namestring
IDE Group
Legal namestring
I D & E Pty Ltd
Websiteurl
idegroup.com.au
Company typeenum
Private
Founded yearint
2003
Descriptiontext

IDE Group is an Australian MedTech commercialisation and product development partner founded in 2003 by George Sidis and headquartered in Leichhardt, NSW, operating under the legal entity I D & E Pty Ltd. The firm offers end-to-end services spanning opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, market launch and distribution, human factors and usability engineering, plus a dedicated MedTech Simulation Usability Lab. Rather than a consulting or advisory model, IDE Group explicitly positions on a 'We do and build' execution approach, with a project portfolio that includes the OKO Ophthalmic Auto-Injector, Bayer's MEDRAD Centargo CT Injector, ResMed's Pixi pediatric sleep apnea mask, Unilife's Safety Syringe, and diagnostic and radiotherapy devices for Atomo Diagnostics, Truscreen, Visionsearch, and Nano-X.

The company serves five MedTech verticals — Connected Care, Drug Delivery, Point-of-Care Diagnostics, Surgical Devices, and Respiratory Care — and generates revenue through bespoke professional services engagements, with pricing not publicly disclosed. GTM is primarily enterprise field sales through direct client engagement with MedTech companies, pharmaceutical firms, and medical device startups. The company maintains a tri-regional delivery footprint across APAC (Leichhardt), Europe (Rotterdam), and North America (Newtown Square PA, Minneapolis MN), and runs the annual Building Better Futures for Health (BBFH) Challenge in conjunction with the MTAA MedTech Conference as an ecosystem and deal-sourcing mechanism.

No public revenue, ARR, or institutional funding history is disclosed. The firm received a $776,280 grant from MTPConnect in June 2025 and operates with a 101-250 employee base, implying a mid-sized private services firm in growth mode rather than a scaled platform.

Short descriptiontext

IDE Group is an Australian MedTech commercialisation and product development partner offering end-to-end services from design through regulatory, manufacturing, and market launch to medtech companies, pharma firms, and device startups across APAC, Europe, and North America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medtech product development, medical device commercialisation, regulatory affairs services, drug delivery development, human factors engineering
Industry1 code
PRIMARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation
NAICS code4 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Computer Systems Design Services541512
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Health Services8000
Product category
Medical Device Design & Commercialisation Services
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1MedTech Innovation & Commercialisation Services
TypeProfessional Services
Description

IDE Group generates revenue through providing comprehensive MedTech commercialisation services including product development, regulatory affairs, manufacturing, and market launch support to medtech companies and pharmaceutical partners.

ide.group
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1OKO
Description

A breakthrough auto-injection system for ophthalmic drug delivery, ensuring accurate dosing, safer procedures, and faster workflows.

ide.group
Core offering1 text field

IDE Group is a MedTech commercialisation and innovation partner that provides end-to-end services for medical device companies and pharmaceutical partners. The company operates across the full product lifecycle — opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, market launch and distribution, and human factors/usability engineering — across five MedTech sectors: Connected Care, Drug Delivery, Point-of-Care Diagnostics, Surgical Devices, and Respiratory Care. The firm also owns the proprietary OKO Ophthalmic Auto-Injector brand.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Successful commercialisation of multiple medical devices including OKO auto-injector, MEDRAD Centargo CT Injector, ResMed Pixi Mask
Product overview1 text field

IDE Group is a MedTech commercialization and innovation partner offering end-to-end services across five key sectors: Connected Care, Drug Delivery, Point-of-Care Diagnostics, Respiratory Care, and Surgical Devices. Rather than a single unified product, IDE Group operates as a service provider delivering specialized capabilities including opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, and market launch. Their portfolio consists of client-developed products including the OKO Ophthalmic Auto-Injector, MEDRAD Centargo CT Injector, Atomo Diagnostics HIV Rapid Test, Unilife Safety Syringe, Truscreen Cervical Cancer Screening, Visionsearch Bioamplifier, ResMed Pixi Mask, and Nano-X Patient Rotation System. They also operate a Simulation Usability Lab in Minneapolis for human factors testing.

Product and service3 records
1MedTech End-to-End Commercialisation Services
CategoryMedTech Product Development Services
Description

Integrated product development, regulatory affairs, manufacturing, and market launch services for medical device and pharmaceutical companies. Spans opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, and market launch and distribution across Connected Care, Drug Delivery, Point-of-Care Diagnostics, Surgical Devices, and Respiratory Care sectors.

2MedTech Simulation Usability Lab
CategoryHuman Factors & Usability Engineering Services
Description

State-of-the-art facility located in Minneapolis, USA, providing human factors and usability engineering testing and validation for medical devices with real-world simulation capabilities. Offered to medical device manufacturers needing formal human factors validation as part of regulatory submissions.

3OKO Ophthalmic Auto-Injector
CategoryOphthalmic Drug Delivery Device
Description

A proprietary breakthrough auto-injection system for ophthalmic drug delivery developed by IDE Group under its OKO sub-brand. Ensures accurate dosing, safer procedures, and faster workflows, improving patient outcomes and enhancing clinic productivity. The device is positioned for ophthalmology clinics and pharmaceutical partners delivering ophthalmic therapeutics.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based product development firm specialising in medical devices, wearables, and connected health — directly comparable to IDE Group's connected care and surgical devices verticals with similar mid-market positioning.

TypeDirect peer
Description

US MedTech and life sciences product development and regulatory services firm serving startups through large device manufacturers — overlaps IDE Group's mix of early-stage and enterprise clients across diagnostics, surgical, and connected care segments.

TypeBroad incumbent
Description

Large applied science and technology development organisation with a significant medical device and life sciences practice — broader and better-capitalised than IDE Group but competes for complex MedTech commercialisation mandates.

TypeDirect peer
Description

US-based medical device and drug delivery product design and contract manufacturing firm — directly comparable to IDE Group's drug delivery, point-of-care diagnostics, and combination product development offerings.

TypeDirect peer
Description

PE-backed global MedTech design, development, and commercialisation services platform combining Ximedica, Quartesian, and other acquired firms — competes head-to-head with IDE Group for enterprise medical device development and regulatory engagements.

TypeOthers
Description

Specialised human factors and usability engineering consultancy serving the MedTech industry — adjacent rather than directly competitive, but overlaps with IDE Group's Simulation Usability Lab capability in Minneapolis.

TypeBroad incumbent
Description

Large UK-based technology consultancy with a deep MedTech practice covering product development, human factors, and regulatory — broader portfolio than IDE Group but directly overlapping on complex medical device and drug delivery programmes.

8Mindflow Design
TypeDirect peer
Description

Mid-sized MedTech product development consultancy offering mechanical, software, and regulatory services — comparable in scale and service breadth to IDE Group, particularly across surgical and diagnostic device programmes.

TypeDirect peer
Description

US MedTech product development firm specialising in design, human factors, and regulatory services for medical devices — comparable in service mix, size tier, and therapeutic focus to IDE Group's surgical, diagnostic, and respiratory verticals.

TypeDirect peer
Description

Canadian MedTech product development firm providing end-to-end design, engineering, regulatory, and manufacturing services — directly comparable to IDE Group's 'opportunity discovery to market launch' value proposition across similar client segments and therapeutic areas.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IDE Group

Medical Device Design & Commercialisation Servicesidegroup.com.au

IDE Group is an Australian MedTech commercialisation and product development partner offering end-to-end services from design through regulatory, manufacturing, and market launch to medtech companies, pharma firms, and device startups across APAC, Europe, and North America.

What IDE Group does

IDE Group is an Australian MedTech commercialisation and product development partner founded in 2003 by George Sidis and headquartered in Leichhardt, NSW, operating under the legal entity I D & E Pty Ltd. The firm offers end-to-end services spanning opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, market launch and distribution, human factors and usability engineering, plus a dedicated MedTech Simulation Usability Lab. Rather than a consulting or advisory model, IDE Group explicitly positions on a 'We do and build' execution approach, with a project portfolio that includes the OKO Ophthalmic Auto-Injector, Bayer's MEDRAD Centargo CT Injector, ResMed's Pixi pediatric sleep apnea mask, Unilife's Safety Syringe, and diagnostic and radiotherapy devices for Atomo Diagnostics, Truscreen, Visionsearch, and Nano-X.

The company serves five MedTech verticals — Connected Care, Drug Delivery, Point-of-Care Diagnostics, Surgical Devices, and Respiratory Care — and generates revenue through bespoke professional services engagements, with pricing not publicly disclosed. GTM is primarily enterprise field sales through direct client engagement with MedTech companies, pharmaceutical firms, and medical device startups. The company maintains a tri-regional delivery footprint across APAC (Leichhardt), Europe (Rotterdam), and North America (Newtown Square PA, Minneapolis MN), and runs the annual Building Better Futures for Health (BBFH) Challenge in conjunction with the MTAA MedTech Conference as an ecosystem and deal-sourcing mechanism.

No public revenue, ARR, or institutional funding history is disclosed. The firm received a $776,280 grant from MTPConnect in June 2025 and operates with a 101-250 employee base, implying a mid-sized private services firm in growth mode rather than a scaled platform.

IDE Group firmographics

Firmographics
Name
IDE Group
Legal name
I D & E Pty Ltd
Website
https://idegroup.com.au
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
101–250 employees
Short description
IDE Group is an Australian MedTech commercialisation and product development partner offering end-to-end services from design through regulatory, manufacturing, and market launch to medtech companies, pharma firms, and device startups across APAC, Europe, and North America.
Ownership category
akta.pro rank

IDE Group industry classification

Industry
Product category
Medical Device Design & Commercialisation Services
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Computer Systems Design Services (541512)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)
akta.pro industry
PRIMARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation

Keywords

  • Medtech product development
  • Medical device commercialisation
  • Regulatory affairs services
  • Drug delivery development
  • Human factors engineering

Where IDE Group is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices4 records

Markets served

IDE Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. MedTech Innovation & Commercialisation Services: IDE Group generates revenue through providing comprehensive MedTech commercialisation services including product development, regulatory affairs, manufacturing, and market launch support to medtech companies and pharmaceutical partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

IDE Group product offering

Product offering

Core offering

IDE Group is a MedTech commercialisation and innovation partner that provides end-to-end services for medical device companies and pharmaceutical partners. The company operates across the full product lifecycle — opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, market launch and distribution, and human factors/usability engineering — across five MedTech sectors: Connected Care, Drug Delivery, Point-of-Care Diagnostics, Surgical Devices, and Respiratory Care. The firm also owns the proprietary OKO Ophthalmic Auto-Injector brand.

Product overview

IDE Group is a MedTech commercialization and innovation partner offering end-to-end services across five key sectors: Connected Care, Drug Delivery, Point-of-Care Diagnostics, Respiratory Care, and Surgical Devices. Rather than a single unified product, IDE Group operates as a service provider delivering specialized capabilities including opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, and market launch. Their portfolio consists of client-developed products including the OKO Ophthalmic Auto-Injector, MEDRAD Centargo CT Injector, Atomo Diagnostics HIV Rapid Test, Unilife Safety Syringe, Truscreen Cervical Cancer Screening, Visionsearch Bioamplifier, ResMed Pixi Mask, and Nano-X Patient Rotation System. They also operate a Simulation Usability Lab in Minneapolis for human factors testing.

Differentiator

Problem solved

Functional benefit

Brands

  • OKO: A breakthrough auto-injection system for ophthalmic drug delivery, ensuring accurate dosing, safer procedures, and faster workflows.

Products and services

  • MedTech End-to-End Commercialisation Services Integrated product development, regulatory affairs, manufacturing, and market launch services for medical device and pharmaceutical companies. Spans opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, and market launch and distribution across Connected Care, Drug Delivery, Point-of-Care Diagnostics, Surgical Devices, and Respiratory Care sectors.
  • MedTech Simulation Usability Lab State-of-the-art facility located in Minneapolis, USA, providing human factors and usability engineering testing and validation for medical devices with real-world simulation capabilities. Offered to medical device manufacturers needing formal human factors validation as part of regulatory submissions.
  • OKO Ophthalmic Auto-Injector A proprietary breakthrough auto-injection system for ophthalmic drug delivery developed by IDE Group under its OKO sub-brand. Ensures accurate dosing, safer procedures, and faster workflows, improving patient outcomes and enhancing clinic productivity. The device is positioned for ophthalmology clinics and pharmaceutical partners delivering ophthalmic therapeutics.

Quantifiable outcome

  • Successful commercialisation of multiple medical devices including OKO auto-injector, MEDRAD Centargo CT Injector, ResMed Pixi Mask

Companies that use IDE Group

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles2 records

IDE Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

IDE Group partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

IDE Group competitors and assessment

Company assessment

Direct peers

  • Product Creation Studio: US-based product development firm specialising in medical devices, wearables, and connected health — directly comparable to IDE Group's connected care and surgical devices verticals with similar mid-market positioning.
  • Triple Ring Technologies: US MedTech and life sciences product development and regulatory services firm serving startups through large device manufacturers — overlaps IDE Group's mix of early-stage and enterprise clients across diagnostics, surgical, and connected care segments.
  • Gilero: US-based medical device and drug delivery product design and contract manufacturing firm — directly comparable to IDE Group's drug delivery, point-of-care diagnostics, and combination product development offerings.
  • Veranex (formerly Ximedica): PE-backed global MedTech design, development, and commercialisation services platform combining Ximedica, Quartesian, and other acquired firms — competes head-to-head with IDE Group for enterprise medical device development and regulatory engagements.
  • Mindflow Design: Mid-sized MedTech product development consultancy offering mechanical, software, and regulatory services — comparable in scale and service breadth to IDE Group, particularly across surgical and diagnostic device programmes.
  • HS Design: US MedTech product development firm specialising in design, human factors, and regulatory services for medical devices — comparable in service mix, size tier, and therapeutic focus to IDE Group's surgical, diagnostic, and respiratory verticals.
  • StarFish Medical: Canadian MedTech product development firm providing end-to-end design, engineering, regulatory, and manufacturing services — directly comparable to IDE Group's 'opportunity discovery to market launch' value proposition across similar client segments and therapeutic areas.

Broad incumbents

  • Battelle: Large applied science and technology development organisation with a significant medical device and life sciences practice — broader and better-capitalised than IDE Group but competes for complex MedTech commercialisation mandates.
  • Cambridge Consultants: Large UK-based technology consultancy with a deep MedTech practice covering product development, human factors, and regulatory — broader portfolio than IDE Group but directly overlapping on complex medical device and drug delivery programmes.

Others

  • Medical Device Usability: Specialised human factors and usability engineering consultancy serving the MedTech industry — adjacent rather than directly competitive, but overlaps with IDE Group's Simulation Usability Lab capability in Minneapolis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

IDE Group social profiles

Digital presence

IDE Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IDE Group leadership team

Management profile

Number of profiles

Profiles1 record

IDE Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IDE Group M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDE Group

What does IDE Group do?

IDE Group is a MedTech commercialisation and innovation partner that provides end-to-end services for medical device companies and pharmaceutical partners. The company operates across the full product lifecycle — opportunity discovery, business strategy, product development, software solutions, quality assurance, regulatory affairs, manufacturing, market launch and distribution, and human factors/usability engineering — across five MedTech sectors: Connected Care, Drug Delivery, Point-of-Care Diagnostics, Surgical Devices, and Respiratory Care. The firm also owns the proprietary OKO Ophthalmic Auto-Injector brand.

Is IDE Group a public or private company?

IDE Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was IDE Group founded?

IDE Group was founded in 2003. It employs 101 to 250 people.

Where is IDE Group based?

IDE Group is headquartered in Sydney, Australia, in the Oceania region.

How does IDE Group make money?

One revenue line is on record: medTech Innovation & Commercialisation Services.

Who are IDE Group's main competitors?

Direct peers on record are Product Creation Studio, Triple Ring Technologies, Gilero, Veranex (formerly Ximedica), Mindflow Design, HS Design and StarFish Medical. Broad incumbents are Battelle and Cambridge Consultants. Medical Device Usability is listed as an others.

Does IDE Group have an API?

No public API is recorded for IDE Group.

What industry is IDE Group in?

IDE Group's product category is Medical Device Design & Commercialisation Services. Its primary akta.pro industry code is BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals